{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:11:17Z","timestamp":1777378277508,"version":"3.51.4"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.591897","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T12:33:50Z","timestamp":1601469230000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["As Plain as the Nose on Your Face: The Case for A Nasal (Mucosal) Route of Vaccine Administration for Covid-19 Disease Prevention"],"prefix":"10.3389","volume":"11","author":[{"given":"Craig R.","family":"Travis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,9,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"eabc8413","DOI":"10.1126\/sciimmunol.abc8413","article-title":"The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients","volume":"5","author":"Premkumar","year":"2020","journal-title":"Sci Immunol"},{"key":"B2","unstructured":""},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics11080375\\","article-title":"Mucosal Vaccination via the Respiratory Tract","volume":"11","author":"Hellfritzsch","year":"2019","journal-title":"Pharmaceutics"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201011-1783OC","article-title":"Potential of nasopharynx-associated lymphoid tissue for vaccine responses in the airways","volume":"183","author":"Brandtzaeg","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1056\/NEJM197101142840201","article-title":"Effect of tonsillectomy and adenoidectomy on nasopharyngeal antibody response to poliovirus","volume":"284","author":"Ogra","year":"1971","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.10.6259","article-title":"IgA class switch occurs in the organized nasopharynx- and gut-associated lymphoid tissue, but not in the diffuse lamina propria of airways and gut","volume":"172","author":"Shikina","year":"2004","journal-title":"J\u00a0Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2002-0230OC","article-title":"Human nasal mucosa contains antigen-presenting cells of strikingly different functional phenotypes","volume":"30","author":"Jahnsen","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaz5807","article-title":"Structure of the secretory immunoglobulin A core","volume":"367","author":"Kumar","year":"2020","journal-title":"Sci (New York NY)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e85582","DOI":"10.1371\/journal.pone.0085582","article-title":"Comparison of antiviral activity between IgA and IgG specific to influenza virus hemagglutinin: increased potential of IgA for heterosubtypic immunity","volume":"9","author":"Muramatsu","year":"2014","journal-title":"PLoS One"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.76.21.10972-10979.2002","article-title":"Multiple functions of immunoglobulin A in mucosal defense against viruses: an in vitro measles virus model","volume":"76","author":"Yan","year":"2002","journal-title":"J Virol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3390\/pathogens3020390","article-title":"Secretory IgA is Concentrated in the Outer Layer of Colonic Mucus along with Gut Bacteria","volume":"3","author":"Rogier","year":"2014","journal-title":"Pathogens"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.5.2816","article-title":"IL-8 released constitutively by primary bronchial epithelial cells in culture forms an inactive complex with secretory component","volume":"167","author":"Marshall","year":"2001","journal-title":"J Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e138999","DOI":"10.1172\/jci.insight.138999","article-title":"Neutrophil extracellular traps in COVID-19","volume":"5","author":"Zuo","year":"2020","journal-title":"JCI Insight"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.15.6901","article-title":"Intracellular neutralization of virus by immunoglobulin A antibodies","volume":"89","author":"Mazanec","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B15","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.163.3.1382","article-title":"Nasal-associated lymphoid tissue: phenotypic and functional evidence for the primary role of peripheral node addressin in naive lymphocyte adhesion to high endothelial venules in a mucosal site","volume":"163","author":"Csencsits","year":"1999","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200211)32:11<3029::AID-IMMU3029>3.0.CO;2-9","article-title":"Mucosal addressin expression and binding-interactions with naive lymphocytes vary among the cranial, oral, and nasal-associated lymphoid tissues","volume":"32","author":"Csencsits","year":"2002","journal-title":"Eur J Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3402\/jom.v5i0.20401","article-title":"Secretory immunity with special reference to the oral cavity","volume":"5","author":"Brandtzaeg","year":"2013","journal-title":"J\u00a0Oral Microbiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20010685","article-title":"Lymphocyte homing to bronchus-associated lymphoid tissue (BALT) is mediated by L-selectin\/PNAd, alpha4beta1 integrin\/VCAM-1, and LFA-1 adhesion pathways","volume":"197","author":"Xu","year":"2003","journal-title":"J Exp Med"},{"key":"B19","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.160.4.2000","article-title":"HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160","volume":"160","author":"VanCott","year":"1998","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1620194114","article-title":"Nasal-associated lymphoid tissues (NALTs) support the recall but not priming of influenza virus-specific cytotoxic T cells","volume":"114","author":"Pizzolla","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01505-14","article-title":"Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection","volume":"88","author":"Channappanavar","year":"2014","journal-title":"J Virol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0308-3","article-title":"COVID-19: immunopathology and its implications for therapy","volume":"20","author":"Cao","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2020.108516","article-title":"COVID-19 pneumonia: CD8+ T and NK cells are decreased in number but compensatory increased in cytotoxic potential","volume":"218","author":"Jiang","year":"2020","journal-title":"Clin Immunol (Orlando Fla)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2588-y","article-title":"Longitudinal analyses reveal immunological misfiring in severe COVID-19","volume":"584","author":"Lucas","year":"2020","journal-title":"Nature"},{"key":"B25","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2010.07.068","article-title":"Robust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1","volume":"28","author":"Sealy","year":"2010","journal-title":"Vaccine"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1438791","article-title":"IgA polymerization contributes to efficient virus neutralization on human upper respiratory mucosa after intranasal inactivated influenza vaccine administration","volume":"14","author":"Terauchi","year":"2018","journal-title":"Hum vaccines Immunother"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.64.5.1706-1713.1996","article-title":"Intranasal and intramuscular proteosome-staphylococcal enterotoxin B (SEB) toxoid vaccines: immunogenicity and efficacy against lethal SEB intoxication in mice","volume":"64","author":"Lowell","year":"1996","journal-title":"Infect Immun"},{"key":"B28","doi-asserted-by":"publisher","first-page":"S1198","DOI":"10.1016\/j.cmi.2020.07.009","article-title":"Disappearance of antibodies to SARS-CoV-2 in a -COVID-19 patient after recovery","author":"Liu","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.11.5416-5420.2001","article-title":"Nasal-associated lymphoid tissue is a site of long-term virus-specific antibody production following respiratory virus infection of mice","volume":"75","author":"Liang","year":"2001","journal-title":"J Virol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"B31","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.cell.2020.05.042","article-title":"SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract","volume":"182","author":"Hou","year":"2020","journal-title":"Cell"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.24.15511-15524.2005","article-title":"Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs","volume":"79","author":"Sims","year":"2005","journal-title":"J Virol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02292-10","article-title":"Epithelial cells lining salivary gland ducts are early target cells of severe acute respiratory syndrome coronavirus infection in the upper respiratory tracts of rhesus macaques","volume":"85","author":"Liu","year":"2011","journal-title":"J Virol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1101\/2020.08.01.20166553","article-title":"Mucosal versus systemic antibody responses to SARS-CoV-2 antigens in COVID-19 patients","author":"Isho","year":"2020","journal-title":"medRxiv"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2001526","DOI":"10.1183\/13993003.01526-2020","article-title":"Distinct features of SARS-CoV-2-specific IgA response in COVID-19 patients","volume":"56","author":"Yu","year":"2020","journal-title":"Eur Respir J"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-020-0474-z","article-title":"Serum IgA, IgM, and IgG responses in COVID-19","volume":"17","author":"Ma","year":"2020","journal-title":"Cell Mol Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1101\/2020.08.07.20170258","article-title":"Salivary anti-SARS-CoV-2 IgA as an accessible biomarker of mucosal immunity against COVID-19","author":"Varadhachary","year":"2020","journal-title":"medRxiv preprint server Health Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/mi.2015.127","article-title":"Spatiotemporal interplay of severe acute respiratory syndrome coronavirus and respiratory mucosal cells drives viral dissemination in rhesus macaques","volume":"9","author":"Liu","year":"2016","journal-title":"Mucosal Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2196-x","article-title":"Virological assessment of hospitalized patients with COVID-2019","volume":"581","author":"W\u00f6lfel","year":"2020","journal-title":"Nature"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-0321-6","article-title":"The potential danger of suboptimal antibody responses in COVID-19","volume":"20","author":"Iwasaki","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41577-020-0389-z","article-title":"Pre-existing immunity to SARS-CoV-2: the knowns and unknowns","author":"Sette","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00278-10","article-title":"Prevalence of antibodies to four human coronaviruses is lower in nasal secretions than in serum","volume":"17","author":"Gorse","year":"2010","journal-title":"Clin Vaccine Immunol CVI"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2598-9","article-title":"SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19","author":"Braun","year":"2020","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-020-0577-1","article-title":"Implications of antibody-dependent enhancement of infection for SARS-CoV-2 countermeasures","volume":"38","author":"Eroshenko","year":"2020","journal-title":"Nat Biotechnol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/nri1334","article-title":"T-cell-B-cell cooperation","volume":"4","author":"Mitchison","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12367","article-title":"Fc receptors in antibody-dependent enhancement of viral infections","volume":"268","author":"Taylor","year":"2015","journal-title":"Immunol Rev"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01540","article-title":"The Neonatal Fc Receptor (FcRn): A Misnomer","volume":"10","author":"Pyzik","year":"2019","journal-title":"Front Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.02991","article-title":"Viral-Induced Enhanced Disease Illness","volume":"9","author":"Smatti","year":"2018","journal-title":"Front Microbiol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00671-11","article-title":"Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent Fc\u03b3R pathway","volume":"85","author":"Jaume","year":"2011","journal-title":"J Virol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1743-422X-11-82","article-title":"Antibody-dependent infection of human macrophages by severe acute respiratory syndrome coronavirus","volume":"11","author":"Yip","year":"2014","journal-title":"Virol J"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.9.6337","article-title":"Prior immunization with severe acute respiratory syndrome (SARS)-associated coronavirus (SARS-CoV) nucleocapsid protein causes severe pneumonia in mice infected with SARS-CoV","volume":"181","author":"Yasui","year":"2008","journal-title":"J Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.matbio.2018.06.006","article-title":"Defective lung function following influenza virus is due to prolonged, reversible hyaluronan synthesis","volume":"80","author":"Bell","year":"2019","journal-title":"Matrix Biol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.3.855","article-title":"Modulation of human immunodeficiency virus type 1 infection of human monocytes by IgA","volume":"172","author":"Janoff","year":"1995","journal-title":"J\u00a0Infect Dis"},{"key":"B54","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.154.11.6163","article-title":"High prevalence of serum IgA HIV-1 infection-enhancing antibodies in HIV-infected persons. Masking by IgG","volume":"154","author":"Kozlowski","year":"1995","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02015-19","article-title":"Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry","volume":"94","author":"Wan","year":"2020","journal-title":"J Virol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e123158","DOI":"10.1172\/jci.insight.123158","article-title":"Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection","volume":"4","author":"Liu","year":"2019","journal-title":"JCI Insight"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1369\/0022155417705095","article-title":"Distribution of FcRn Across Species and Tissues","volume":"65","author":"Latvala","year":"2017","journal-title":"J Histochem Cytochem"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200809122","article-title":"The recycling and transcytotic pathways for IgG transport by FcRn are distinct and display an inherent polarity","volume":"185","author":"Tzaban","year":"2009","journal-title":"J Cell Biol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e04-08-0735","article-title":"From sorting endosomes to exocytosis: association of Rab4 and Rab11 GTPases with the Fc receptor, FcRn, during recycling","volume":"16","author":"Ward","year":"2005","journal-title":"Mol Biol Cell"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e1004502","DOI":"10.1371\/journal.ppat.1004502","article-title":"Coronavirus cell entry occurs through the endo-\/lysosomal pathway in a proteolysis-dependent manner","volume":"10","author":"Burkard","year":"2014","journal-title":"PLoS Pathog"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3390\/cells9071583","article-title":"Vasculopathy and Coagulopathy Associated with SARS-CoV-2 Infection","volume":"9","author":"Lab\u00f2","year":"2020","journal-title":"Cells"},{"key":"B62","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/s41577-020-0350-1","article-title":"Kawasaki disease linked to COVID-19 in children","volume":"20","author":"Moreira","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1114195","article-title":"Induction of mucosal immunity through systemic immunization: Phantom or reality","volume":"12","author":"Su","year":"2016","journal-title":"Hum Vaccines Immunother"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1128\/CVI.00214-16","article-title":"Parenteral Vaccination Can Be an Effective Means of Inducing Protective Mucosal Responses","volume":"23","author":"Clements","year":"2016","journal-title":"Clin Vaccine Immunol CVI"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1042\/bst0250466","article-title":"IgA antibody as a non-inflammatory regulator of immunity","volume":"25","author":"Russell","year":"1997","journal-title":"Biochem Soc Trans"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1994.tb03371.x","article-title":"All forms of human IgA antibodies bound to antigen interfere with complement (C3) fixation induced by IgG or by antigen alone","volume":"39","author":"Nikolova","year":"1994","journal-title":"Scand J Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.9.5633","article-title":"Perspectives on mucosal vaccines: is mucosal tolerance a barrier","volume":"179","author":"Mestecky","year":"2007","journal-title":"J Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2000513","article-title":"Inflammasomes and Pyroptosis as Therapeutic Targets for COVID-19","volume":"205","author":"Yap","year":"2020","journal-title":"J Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.2.948","article-title":"Intranasal vaccination of recombinant adeno-associated virus encoding receptor-binding domain of severe acute respiratory syndrome coronavirus (SARS-CoV) spike protein induces strong mucosal immune responses and provides long-term protection against SARS-CoV infection","volume":"180","author":"Du","year":"2008","journal-title":"J Immunol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"e0220196","DOI":"10.1371\/journal.pone.0220196","article-title":"Superior immune responses induced by intranasal immunization with recombinant adenovirus-based vaccine expressing full-length Spike protein of Middle East respiratory syndrome coronavirus","volume":"14","author":"Kim","year":"2019","journal-title":"PLoS One"},{"key":"B71","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.cell.2020.06.011","article-title":"A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies","volume":"182","author":"Hassan","year":"2020","journal-title":"Cell"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2014.01.006","article-title":"Mucosal adjuvants for vaccines to control upper respiratory infections in the elderly","volume":"54","author":"Fujihashi","year":"2014","journal-title":"Exp Gerontol"},{"key":"B73","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.02171","article-title":"Immunogenicity and Toxicity of Different Adjuvants Can Be Characterized by Profiling Lung Biomarker Genes After Nasal Immunization","volume":"11","author":"Sasaki","year":"2020","journal-title":"Front Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2020.04.005","article-title":"The potential role of Th17 immune responses in coronavirus immunopathology and vaccine-induced immune enhancement","volume":"22","author":"Hotez","year":"2020","journal-title":"Microbes Infect"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/nri1728","article-title":"Immunization without needles","volume":"5","author":"Mitragotri","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"B76","volume-title":"State of the World\u2019s Vaccines and Immunization","year":"1996"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.591897\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,8]],"date-time":"2023-10-08T19:03:22Z","timestamp":1696791802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.591897\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,30]]},"references-count":76,"alternative-id":["10.3389\/fimmu.2020.591897"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.591897","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,30]]},"article-number":"591897"}}